AM Gewirtz
- Topics
- Platelet Disorders and Treatments (13 papers)Chronic Myeloid Leukemia Treatments (5 papers)Blood properties and coagulation (4 papers)
- Journals
- BloodExperimental HematologyPubMed
- Partner nations
- United StatesItaly
In The Last Decade
AM Gewirtz
24 papers receiving 470 citations
Peers
Comparison fields: 5 of 51
- Hematology 383
- Genetics 155
- Molecular Biology 103
- Immunology 93
- Pulmonary and Respiratory Medicine 79
Countries citing papers authored by AM Gewirtz
This map shows the geographic impact of AM Gewirtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AM Gewirtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AM Gewirtz more than expected).
Fields of papers citing papers by AM Gewirtz
This network shows the impact of papers produced by AM Gewirtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AM Gewirtz. The network helps show where AM Gewirtz may publish in the future.
Co-authorship network of co-authors of AM Gewirtz
This figure shows the co-authorship network connecting the top 25 collaborators of AM Gewirtz. A scholar is included among the top collaborators of AM Gewirtz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AM Gewirtz. AM Gewirtz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Developing oligonucleotide therapeutics for human leukemia. | 4 |
| 2 | 12 | |
| 3 | Perturbing gene expression with oligodeoxynucleotides: research and potential therapeutic applications. | 5 |
| 4 | 19 | |
| 5 | 38 | |
| 6 | Treatment of chronic myelogenous leukemia (CML) with c-myb antisense oligodeoxynucleotides. | 11 |
| 7 | 3 | |
| 8 | 34 | |
| 9 | Bone marrow purging with antisense oligodeoxynucleotides. | 1 |
| 10 | Use of in situ hybridization to study human megakaryocyte gene expression. | 3 |
| 11 | 18 | |
| 12 | 2 | |
| 13 | Cellular regulation of human megakaryocytopoiesis in vitro. | 7 |
| 14 | 4 | |
| 15 | 71 | |
| 16 | 37 | |
| 17 | 49 | |
| 18 | 5 | |
| 19 | 4 | |
| 20 | 64 |
About AM Gewirtz
AM Gewirtz is a scholar working on Hematology, Genetics and Gastroenterology, having authored 24 papers that have together received 500 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (13 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Blood properties and coagulation (4 papers). The work is most often cited by research in Hematology (383 citations), Genetics (155 citations) and Immunology and Allergy (32 citations). AM Gewirtz has collaborated with scholars based in United States and Italy. Frequent co-authors include E Bruno, EJ Jr Benz, TA Rado, RW Colman, Mariusz Z. Ratajczak, AH Schmaier, S. M. Luger, JS Moore, Catherine Labbaye and Gianfranco Mattia. Their work appears in journals such as Blood, Experimental Hematology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.